Business Ideas

Glenmark Generics files IPO prospectus with Sebi

Drug maker Glenmark Pharmaceuticals today said its subsidiary Glenmark Generics has filed the draft prospectus with marker regulator Securities and Exchange Board of India (SebiI) for an initial public offer (IPO). - Cost audit should be included in Clause 49: Panel - Bharati expects nod for Great Offshore open offer soon - An exchange of their own - Bharati Shipyard mulls Rs 200-cr capex over two years - Sahara realty arm files IPO prospectus, to raise Rs 3,450 cr - Sebi wants listed firms to provide sufficient info to market "Glenmark Generics, has, on September 30, filed the draft red herring prospectus (DRHP) with Sebi for an Initial Public Offer," Glenmark Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE). Drug maker did not disclose any further details about the public issue.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Disney looks at regional languages
Walt Disney Company India Private Limited would design its Disney Channel (DC) and Hungama Channel programmes in regional languages, Vijay Subramaniam, strategic sales and market development director, Walt Disney Television International (India).
Popular Articles
Modern furniture stores in NY

UN to cut staff by 40% in Pak on security concerns
The United Nations plans to reduce about 40 per cent of its staff in Pakistan by realigning their deployment due to growing security concerns in the wake of a wave of terrorist attacks across the country.

Sensex falls 155 points on weak global cues
The Sensex fell 0.88 per cent, or 155.02 points, at 17,486.06, as weak global markets encouraged investors to lock in profits in outsourcers such as Tata Consultancy Services and Infosys Technologies.

© Copyright 2009